Article Per Year (5 Year)
p-Index From 2021 - 2026
0.23
P-Index
This Author published in this journals
All Journal Journal for Technology and Science
Bushra Hamad Obaid
Polytechnic College / Al–Qadisiyah, Al-Furat Al- Awsat Technical University, Iraq
Aerospace Engineering Automotive Engineering Chemical Engineering, Chemistry & Bioengineering Civil Engineering, Building, Construction & Architecture Electrical & Electronics Engineering

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

 1 
COMPARATIVE IN VITRO EVALUATION OF LL-37 AND STANDARD ANTIBIOTICS AGAINST ESCHERICHIA COLI ISOLATES FROM URINARY TRACT INFECTIONS: A SUSTAINABLE HEALTHCARE PERSPECTIVE Sura A Al-Ganahi; Bushra Hamad Obaid; Robeena Farzand
Journal for Technology and Science Vol. 3 No. 4 (2026): Journal for Technology and Science
Publisher : PT ANTIS INTERNATIONAL PUBLISHER

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.61796/ipteks.v3i4.580

Abstract

Objective: This study aimed to evaluates the in vitro antibacterial activity of the human cathelicidin peptide LL-37 towards E. coli which isolated from UTI patients, as well as to compare its effect with the common antibiotics like amoxicillin-clavulanic acid (AMC), aztreonam (ATM), and ceftriaxone (CRO). Method: In well diffusion test, LL-37 showed a clear inhibition zone, revealing strong antimicrobial activity. The time-kill assay also authorized its bactericidal action, showing a ≥3 log₁₀ CFU/mL reduction within few hours and almost complete killing after 24 hours. Results: The mean zone diameter for LL-37 (18.4 ± 1.7 mm) was obviously greater than AMC (13.2 ± 2.1 mm) (p < 0.01) and higher than ATM (16.1 ± 1.9 mm), although the difference with ATM was not significant (p > 0.05). CRO confirmed smaller zone (14.3 ± 1.8 mm), which kind of highlight the stronger effect of LL-37. Novelty:    The results generally supports the idea that LL-37 could be a promising alternative antimicrobial agent, showing strong activity than some of the usual antibiotics against E. coli. Its possible role in treating drug-resistant UTIs still need more studying, especially now when resistance to β-lactam antibiotics keeps increasing.
Co-Authors Robeena Farzand Sura A Al-Ganahi